Savvy Updates, 9/6/22: Senseonics CFO Leaves, Beta Bionics Trial Data & RIF, Chip-free, Wireless Electronic Skin, Insulin Pill, Cognitive Benefits from Hybrid Closed Loop Systems, Sugar & Microbiome, T1D & Hypothyroidism

Savvy Updates, 9/6/22: Senseonics CFO Leaves, Beta Bionics Trial Data & RIF, Chip-free, Wireless Electronic Skin, Insulin Pill, Cognitive Benefits from Hybrid Closed Loop Systems, Sugar & Microbiome, T1D & Hypothyroidism

Senseonics Announces CFO Transition was published by Senseonics Holdings, Inc., 1 September 2022.   Senseonics, a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems...
Skip to content